Clinical trial Recruiting at 1 site Interventional Ages 65 and up

Rehabilitation program for frail older adults

Official title: Frailty Rehabilitation: A Community-based Intervention to Promote Healthy Aging

Run by McMaster University · NCT03824106 · Data updated 2026-11-12

This study is testing a rehabilitation program to see if it can help frail older adults improve their physical abilities and reduce their risk of mobility issues.

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment324 (estimated)
SponsorMcMaster University
Academic / other
Locations1 site (Hamilton, Ontario)
StatusRecruiting
StartedSeptember 2, 2022
Main results expectedDecember 31, 2025
Study endsDecember 31, 2025
Registry record updatedJuly 6, 2025
Trial IDNCT03824106 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are community-dwelling individuals aged 65 and older who are frail and at high risk for mobility disability.

Probably not a fit

Patients who are currently attending a group exercise program or have significant cognitive impairment may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of a frailty rehabilitation program aimed at improving physical function in community-dwelling older adults aged 65 and above who are frail and at high risk for mobility disability. Participants will be randomly assigned to one of three groups: a control group, an exercise-only group, or a multi-modal rehabilitation group that includes exercise, nutrition, medication review, and supplements. The study will involve 324 participants recruited from YMCA sites, with assessments conducted to evaluate the impact of the rehabilitation program on frailty and sarcopenia. The trial aims to identify essential components of rehabilitation that can help change the trajectory of frailty in older adults.

Why it matters

Potential benefit: If successful, this program could significantly enhance the physical function and quality of life for frail older adults, potentially delaying or preventing mobility disability.

How similar studies have gone: Previous studies have shown that community-based interventions for frailty can be effective, suggesting a promising outlook for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Community-dwelling ≥65 years of age
* Able to independently ambulate 25m with or without walking aid
* At high risk for mobility disability/functional limitations
* Received medical clearance
* Can arrange transportation to the YMCA up to 2x/week
* Proof of being fully vaccinated against COVID-19 and proof of identification

Exclusion Criteria:

* Unable to speak or understand English
* Currently attending a group exercise program
* Currently in a drug optimization study/program
* Currently taking protein supplements daily
* Significant cognitive impairment where they may have difficulty following two-step commands in group exercise
* Receiving palliative/end of life care
* Unstable angina or heart failure
* Unable to attend for more than 20% of trial duration

Where it's running

  • McMaster University - St. Peter's Hospital
    Hamilton, Ontario, Canada
    Recruiting

Study contacts

  • Principal investigator: Alexandra Papaioannou, MD, MSc — McMaster University
  • Study coordinator: Sherri Smith
  • Email: smithsher@hhsc.ca
  • Phone: 905 521 2100

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.